Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

antihistamine

antihistamine is a histamine h1 receptor antagonist.

NMPA: clinical trials
Patents linked 2
Pipeline programs 2
News articles 0
Drug details — antihistamine
Class
—
Route
—
Patents
2
Programs
2
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

antihistamine is a histamine h1 receptor antagonist.

Key facts

INN antihistamine
Mechanism Histamine H1 receptor antagonist
Target Histamine H1 receptor

Mechanism of action

Histamine H1 receptor antagonist

Primary target: Histamine H1 receptor

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 2025101109 Approved · Chinese Academy of · Allergic Rhinitis
  2. antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate) Unknown · Chinese Academy of · Pain

Related & competitor drugs

Browse all drugs
  1. azelastine hydrochloride Histamine H1 receptor antagonist
  2. brompheniramine maleate Histamine H1 receptor antagonist
  3. carbinoxamine maleate Histamine H1 receptor antagonist
  4. cetirizine hydrochloride Histamine H1 receptor antagonist
  5. chlorpheniramine maleate Histamine H1 receptor antagonist
  6. clemastine fumarate Histamine H1 receptor antagonist

Related patents

Browse patents

  1. US 7585520

    Compositions containing both sedative and non-sedative antihistamines and sleep aids

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6827946

    Compositions containing both sedative and non-sedative antihistamines

    Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is antihistamine?

antihistamine is a histamine h1 receptor antagonist.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.